+35.4%
CVS vs SBAC
-3.2%
+38.6%
-16.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | SBAC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.5% | -1.1% | +0.6% | -0.4% |
| 7D | +4.0% | -0.8% | +4.7% | +4.0% |
| 30D | -2.4% | +6.9% | -9.3% | -3.0% |
| 3M | +2.7% | -8.2% | +10.9% | +3.8% |
| 6M | +21.9% | -1.6% | +23.5% | +22.6% |
| YTD | +24.7% | -0.1% | +24.9% | +26.2% |
| 1Y | +35.4% | -0.5% | +35.9% | +36.9% |
| All | +35.4% | -3.2% | +38.6% | +36.9% |
Cumulative growth
Daily Returns
Daily percentage return beside SBAC.
Daily Out/Under-Performance
Portfolio return minus SBAC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SBAC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded SBAC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling